Adam R. Craig

Insider Reports History

Entity
Individual
Location
C/O Innovive Pharmaceuticals, Inc., 555 Madison Avenue, 25 Th Floor, New York, NY
Signature
/s/ Adam R. Craig
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Adam R. Craig:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CTI BIOPHARMA CORP President and CEO, Director Common Stock 0 $9.10 Jun 26, 2023 Direct
CTI BIOPHARMA CORP President and CEO, Director Stock Option (Right to Buy) 0 Jun 26, 2023 Direct

Insider Reports Filed by Adam R. Craig

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CTIC CTI BIOPHARMA CORP Jun 26, 2023 10 -$286K 4 Jun 26, 2023 President and CEO, Director
CTIC CTI BIOPHARMA CORP Mar 14, 2023 1 $0 4 Mar 16, 2023 President and CEO, Director
CTIC CTI BIOPHARMA CORP Jan 24, 2023 6 -$440K 4 Jan 26, 2023 President and CEO, Director
CTIC CTI BIOPHARMA CORP Dec 29, 2022 16 -$589K 4 Jan 3, 2023 President and CEO, Director
CTIC CTI BIOPHARMA CORP Nov 9, 2022 14 -$1.25M 4 Nov 14, 2022 President and CEO, Director
CTIC CTI BIOPHARMA CORP Sep 12, 2022 3 -$1.35M 4 Sep 14, 2022 President and CEO, Director
CTIC CTI BIOPHARMA CORP Aug 16, 2022 1 $27.5K 4 Aug 16, 2022 President and CEO, Director
CTIC CTI BIOPHARMA CORP Jun 30, 2022 10 -$362K 4 Jul 6, 2022 President and CEO, Director
CTIC CTI BIOPHARMA CORP Jun 1, 2022 3 $0 4/A Jun 3, 2022 President and CEO, Director
CTIC CTI BIOPHARMA CORP Dec 31, 2021 2 $6.7K 4 Mar 11, 2022 President and CEO, Director
CTIC CTI BIOPHARMA CORP Jun 30, 2021 3 $16K 4 Dec 2, 2021 President and CEO, Director